Table 4 Acute procedural results. Global and per vein application analysis.
Overall | ||||
---|---|---|---|---|
Total veins (n) | 6715 | |||
Total applications | 12,491 | |||
Applications per vein (n) | 1.8 ± 1.11 | |||
Time per application (s) | 178.5 ± 57.83 | |||
PV potentials; n (%) | 4098 (61.0) | |||
TTE (s) | 52.9 ± 37.02 | |||
Temperature at PVI (°C) | − 33.6 ± 9.92 | |||
PVI with 1st application; (n/%) | 75.8 (6381) | |||
Minimum temperature (°C) | − 45.4 ± 8.20 | |||
Rewarming time (s) | 38.7 ± 20.15 |
Per vein analysis | LSPV A | LIPVB | RSPVC | RIPVD |
---|---|---|---|---|
Total veins (n) | 1537 | 1534 | 1691 | 1660 |
Total applications (n) | 2828 | 2766 | 3059 | 3148 |
Applications per vein | 1.8 ± 1.07 | 1.8 ± 1.01 | 1.8 ± 1.06 | 1.9 ± 1.17 |
Time per application (s) | 179.7 ± 56.14BD | 179.7 ± 59.74AD | 173.6 ± 58.76* | 179.4 ± 57.65AB |
PV potentials (%) | 1110 (72.4)* | 967 (63.2) * | 997 (59.2) * | 834 (50.6) * |
TTE (s) | 52.1 ± 34.14BC | 51 ± 34.3AC | 49.0 ± 38.88AB | 59.0 ± 39.62* |
Temperature at PVI (°C) | − 35.2 ± 9.29D | − 31.3 ± 9.7* | − 33.2 ± 10.78D | − 34.4 ± 9.43C |
PVI with 1st application; n (%) | 1487 (77.67)BCD | 1455 (78.35)AC | 1610 (75.0)ABD | 1552 (73.7)AD |
Total cryotherapy time (s) | 330.3 ± 173.92BCD | 323.8 ± 162.16AC | 314.0 ± 174.86AB | 340.4 ± 193.07A |
Minimum temperature (°C) | − 46.4 ± 8.04* | − 43.4 ± 7.84* | − 47.3 ± 8.07* | − 44.4 ± 8.20* |
Rewarming time (s) | 43.3 ± 22.82* | 36.7 ± 18.94D | 41.0 ± 19.63* | 34.3 ± 17.80B |